drugset / Trial / NCT01712763
Degarelix in the Treatment of Endometriosis Recurrence
RandomizedParallel-groupSingle-blindTreatment
Summary
The long acting GnRH antagonist degarelix will be tested for the treatment of women with endometriosis recurrence compared with classical GnRH analog treatment. Pain symptom disappearance and disease free time during follow-up will be the outcomes for establishing which medical treatment is the best in endometriosis recurrence treatment.
Timeline
- Start
- 2012-11
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Degarelix | Other / unclassified | 120 mg | — |
| Comparator | Leuprolide | Other / unclassified | 11.25 mg/ml | — |